PRICE T ROWE ASSOCIATES INC /MD/ - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 217 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$186
-99.9%
209,418
+8.4%
0.00%
Q3 2022$304,000
+6.7%
193,237
+36.5%
0.00%
Q2 2022$285,000
-6.6%
141,561
+8.3%
0.00%
Q1 2022$305,000
-41.3%
130,715
+16.8%
0.00%
Q4 2021$520,000
-33.2%
111,906
+9.7%
0.00%
Q3 2021$778,000
-35.5%
101,973
-18.1%
0.00%
Q2 2021$1,206,000
+31.9%
124,473
+12.7%
0.00%
Q1 2021$914,000
+13.1%
110,484
-6.7%
0.00%
Q4 2020$808,000
-36.5%
118,375
+3.7%
0.00%
Q3 2020$1,273,000
+179.2%
114,153
+57.4%
0.00%
Q2 2020$456,000
+225.7%
72,546
-4.8%
0.00%
Q1 2020$140,000
-6.0%
76,189
+72.4%
0.00%
Q4 2019$149,000
+77.4%
44,189
+12.4%
0.00%
Q3 2019$84,000
-17.6%
39,325
+2.5%
0.00%
Q2 2019$102,000
+61.9%
38,372
+191.3%
0.00%
Q1 2019$63,000
+103.2%
13,172
+3.1%
0.00%
Q4 2018$31,000
-90.4%
12,772
-82.6%
0.00%
Q3 2018$322,000
-8.0%
73,226
+50.8%
0.00%
Q2 2018$350,000
+52.2%
48,573
+8.7%
0.00%
Q1 2018$230,000
-21.8%
44,696
-42.2%
0.00%
Q4 2017$294,000
+14.8%
77,300
+153.8%
0.00%
Q3 2015$256,00030,4620.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders